Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 2500.00 | 1434.95 | 2262.17 | 4087.92 | 0.5511 | 0.3423 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 5000.00 | 2808.68 | 7437.83 | 7309.71 | 1.0168 | 1.0230 |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 5000.00 | 2808.68 | 7191.33 | 7309.71 | 0.9842 | 0.9774 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 5000.00 | 2808.68 | 7381.67 | 7309.71 | 1.0097 | 1.0137 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 5000.00 | 2808.68 | 7101.67 | 7309.71 | 0.9714 | 0.9578 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 5000.00 | 2808.68 | 6620.17 | 7309.71 | 0.9028 | 0.8512 |
| BT-20 | Erlotinib | 1 | uM | 9 | 5000.00 | 2808.68 | 5891.83 | 7309.71 | 0.8041 | 0.7029 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 5000.00 | 2808.68 | 5421.00 | 7309.71 | 0.7395 | 0.6025 |
| BT-20 | Erlotinib | 10 | uM | 9 | 5000.00 | 2808.68 | 4352.67 | 7309.71 | 0.5932 | 0.3645 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 5000.00 | 2808.68 | 3995.67 | 7309.71 | 0.5441 | 0.2801 |
| MCF 10A | Erlotinib | 0.0033113 | uM | 9 | 156.25 | 46.09 | 246.83 | 260.33 | 0.9541 | 0.9370 |
| MCF 10A | Erlotinib | 0.01 | uM | 9 | 156.25 | 46.09 | 282.67 | 260.33 | 1.0636 | 1.0104 |
| MCF 10A | Erlotinib | 0.031623 | uM | 9 | 156.25 | 46.09 | 350.67 | 260.33 | 1.3608 | 1.2457 |
| MCF 10A | Erlotinib | 0.1 | uM | 9 | 156.25 | 46.09 | 346.83 | 260.33 | 1.3391 | 1.2038 |
| MCF 10A | Erlotinib | 0.31623 | uM | 9 | 156.25 | 46.09 | 229.33 | 260.33 | 0.8724 | 0.8548 |
| MCF 10A | Erlotinib | 1 | uM | 9 | 156.25 | 46.09 | 64.00 | 260.33 | 0.2431 | 0.1228 |
| MCF 10A | Erlotinib | 3.1623 | uM | 9 | 156.25 | 46.09 | 59.33 | 260.33 | 0.2326 | 0.1085 |
| MCF 10A | Erlotinib | 10 | uM | 9 | 156.25 | 46.09 | 51.50 | 260.33 | 0.1986 | 0.0374 |
| MCF 10A | Erlotinib | 19.9526 | uM | 9 | 156.25 | 46.09 | 49.17 | 260.33 | 0.1867 | 0.0074 |
| MCF 10A | Erlotinib | 0.0033113 | uM | 9 | 312.50 | 96.23 | 870.00 | 905.08 | 0.9804 | 0.9772 |
| MCF 10A | Erlotinib | 0.01 | uM | 9 | 312.50 | 96.23 | 926.50 | 905.08 | 1.0266 | 0.9921 |
| MCF 10A | Erlotinib | 0.031623 | uM | 9 | 312.50 | 96.23 | 1335.67 | 905.08 | 1.4874 | 1.2561 |
| MCF 10A | Erlotinib | 0.1 | uM | 9 | 312.50 | 96.23 | 1124.50 | 905.08 | 1.2348 | 1.1266 |
| MCF 10A | Erlotinib | 0.31623 | uM | 9 | 312.50 | 96.23 | 714.83 | 905.08 | 0.8015 | 0.8547 |
| MCF 10A | Erlotinib | 1 | uM | 9 | 312.50 | 96.23 | 130.00 | 905.08 | 0.1451 | 0.0953 |